East China’s Jiangsu province has made every effort to implement the innovation-driven development strategy, accelerate the cultivation of strategic scientific and technological forces, strengthen key core technologies, and promote high-level scientific and technological self-reliance.
Early this year, the Zijinshan Laboratory released a 6G core technology innovation achievement that leads the world. Its communication rate is 10-20 times higher than that of 5G, breaking the publicly reported world record.
At present, the international economic and technological competition is facing a profound adjustment situation, and enterprises must rely on independent innovation to realize the transformation of high-quality development. To this end, Jiangsu established a leading group for major technological innovation platforms in 2019 to select major technological innovation platforms for cultivation.
After more than three years of hard work, Jiangsu has launched Zijinshan Laboratory, Gusu Laboratory, and Taihu Laboratory. In 2021, Zijinshan Laboratory will be officially listed as a national strategic scientific and technological force, becoming the leader of Jiangsu's strategic scientific and technological force.
Authoritative statistics show that Jiangsu has 33 of the 219 technologies that lead the world, accounting for 15.1% of the total.
Frontier Biopharmaceutical Co., Ltd., located in Jiangning Medicine Valley, Nanjing, has achieved zero breakthroughs in new anti-AIDS drugs in China.
The research and development cycle of new drugs is long, the investment is large, and the risks are high. What supports the continuous innovation of Frontier Biopharmaceutical Co., Ltd. for more than ten years is the full life cycle service provided by the Pharmaceutical Valley Industrial Park.
From equity financing to plant construction to industrial chain support, the Pharmaceutical Valley Industrial Park has helped more than 200 biopharmaceutical companies, including Frontier Bio, achieve rapid growth, and 8 of them have been listed on the stock market, becoming industry leaders.
Jiangsu has registered over 330 billion yuan in its R&D investment, accounting for 2.95% of the regional GDP, which is close to the middle level of innovative countries and regions. The number of invention patents per 10,000 people reached 41.2, twice the national average.
